|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1994-7-12
|
|
pubmed:abstractText |
Management of Hodgkin's disease (HD) and large mediastinal adenopathy (LMA) usually includes intensive chemotherapy (CT) with or without radiation therapy (XT) regardless of stage.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5 Suppl 2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
97-100
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7515653-Adolescent,
pubmed-meshheading:7515653-Adult,
pubmed-meshheading:7515653-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7515653-Bleomycin,
pubmed-meshheading:7515653-Combined Modality Therapy,
pubmed-meshheading:7515653-Dacarbazine,
pubmed-meshheading:7515653-Doxorubicin,
pubmed-meshheading:7515653-Female,
pubmed-meshheading:7515653-Hodgkin Disease,
pubmed-meshheading:7515653-Humans,
pubmed-meshheading:7515653-Life Tables,
pubmed-meshheading:7515653-Lomustine,
pubmed-meshheading:7515653-Male,
pubmed-meshheading:7515653-Mechlorethamine,
pubmed-meshheading:7515653-Mediastinal Neoplasms,
pubmed-meshheading:7515653-Middle Aged,
pubmed-meshheading:7515653-Mitoxantrone,
pubmed-meshheading:7515653-Prednisone,
pubmed-meshheading:7515653-Procarbazine,
pubmed-meshheading:7515653-Remission Induction,
pubmed-meshheading:7515653-Treatment Outcome,
pubmed-meshheading:7515653-Vinblastine,
pubmed-meshheading:7515653-Vincristine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
|
|
pubmed:affiliation |
Department of Hematology, University of Texas M. D. Anderson Cancer Center, Houston.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
